Pfizer Zmax Approved For One-Dose-Only Antibiotic Therapy
This article was originally published in The Pink Sheet Daily
Executive Summary
Extended-release azithromycin is approved for treatment of mild-to-moderate acute bacterial sinusitis and community acquired pneumonia in adults, Pfizer says. The company said it withdrew an application for acute bacterial exacerbations of chronic bronchitis while FDA "re-evaluates" how it reviews antibiotics for the indication.
You may also be interested in...
Pfizer Citizen Petition Calls For Recall Of Zithromax Generics
Company also files patent litigation against generic azithromycin manufacturers Teva and Sandoz.
Pfizer Citizen Petition Calls For Recall Of Zithromax Generics
Company also files patent litigation against generic azithromycin manufacturers Teva and Sandoz.
Pfizer’s Zithromax Gets Generic Competition Following ANDA Approvals
Teva, Sandoz and Pliva receive FDA clearance for azithromycin; Greenstone launches authorized generic.